Literature DB >> 8578865

Genetic characterization of a human isolate of Puumala hantavirus from France.

M D Bowen1, H Kariwa, P E Rollin, C J Peters, S T Nichol.   

Abstract

PUU90-13 is a strain of Puumala (PUU) virus (family Bunyaviridae: genus Hantavirus) isolated from a human in northeastern France (Rollin et al., 1995). This report describes the full-length sequences of the small (S) and medium (M) genomic RNAs of PUU90-13. The terminal sequences of both the S and M genomic RNAs were found to be conserved and imperfectly complementary. The S RNA of PUU90-13 is 1847 nt in length and contains the nucleocapsid (N) protein gene and a potential overlapping open reading frame (ORF-2) previously described in other hantaviruses. Statistical analysis of the third base substitution frequency in the N ORFs of PUU90-13 and other PUU viruses suggests that the ORF-2 is functional. The M RNA is 3681 nt in length and encodes the glycoprotein precursor. Both genomic segments share the highest degree of nucleotide and amino acid sequence identity with PUUBerkel, a PUU virus from Germany. Phylogenetic analyses of sequences from both segments indicate that PUU90-13 occupies a distinct Western European PUU virus lineage that it shares with PUUBerkel. Both PUU90-13 and PUUBerkel lack a potential N-linked glycosylation site found on the G2 glycoprotein of other PUU viruses.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8578865     DOI: 10.1016/0168-1702(95)00058-x

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  9 in total

1.  Puumala virus reference strain for hantavirus serodiagnosis in France.

Authors:  J Clement; G van der Groen; P Maes; M Van Ranst
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-01       Impact factor: 3.267

2.  Analysis of hantavirus genetic diversity in Argentina: S segment-derived phylogeny.

Authors:  Marlene C Bohlman; Sergey P Morzunov; John Meissner; Mary Beth Taylor; Kimiko Ishibashi; Joan Rowe; Silvana Levis; Delia Enria; Stephen C St Jeor
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Molecular evolution of Puumala hantavirus.

Authors:  T Sironen; A Vaheri; A Plyusnin
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Cell culture adaptation of Puumala hantavirus changes the infectivity for its natural reservoir, Clethrionomys glareolus, and leads to accumulation of mutants with altered genomic RNA S segment.

Authors:  A Lundkvist; Y Cheng; K B Sjölander; B Niklasson; A Vaheri; A Plyusnin
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  Complete genetic characterization and analysis of isolation of Sin Nombre virus.

Authors:  V E Chizhikov; C F Spiropoulou; S P Morzunov; M C Monroe; C J Peters; S T Nichol
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

6.  Complete genome of a Puumala virus strain from Central Europe.

Authors:  Hanan Sheikh Ali; Stephan Drewes; Vanessa Weber de Melo; Mathias Schlegel; Jona Freise; Martin H Groschup; Gerald Heckel; Rainer G Ulrich
Journal:  Virus Genes       Date:  2014-12-28       Impact factor: 2.332

7.  Puumala hantavirus genome in patients with nephropathia epidemica: correlation of PCR positivity with HLA haplotype and link to viral sequences in local rodents.

Authors:  A Plyusnin; J Hörling; M Kanerva; J Mustonen; Y Cheng; J Partanen; O Vapalahti; S K Kukkonen; J Niemimaa; H Henttonen; B Niklasson; A Lundkvist; A Vaheri
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

8.  Recombination in Tula hantavirus evolution: analysis of genetic lineages from Slovakia.

Authors:  C Sibold; H Meisel; D H Krüger; M Labuda; J Lysy; O Kozuch; M Pejcoch; A Vaheri; A Plyusnin
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

9.  First molecular evidence for Puumala hantavirus in Poland.

Authors:  Hanan Sheikh Ali; Stephan Drewes; Edyta T Sadowska; Magdalena Mikowska; Martin H Groschup; Gerald Heckel; Pawel Koteja; Rainer G Ulrich
Journal:  Viruses       Date:  2014-01-23       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.